Teladoc Health, Inc. (BMV:TDOC)
89.77
+1.26 (1.42%)
At close: Mar 2, 2026
Teladoc Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 781.08 | 1,298 | 1,124 | 918.18 | 893.48 |
Short-Term Investments | - | - | - | - | 2.54 |
Cash & Short-Term Investments | 781.08 | 1,298 | 1,124 | 918.18 | 896.02 |
Cash Growth | -39.84% | 15.54% | 22.38% | 2.47% | 13.91% |
Accounts Receivable | 192.83 | 214.15 | 217.42 | 210.55 | 168.96 |
Other Receivables | 8.83 | 9.81 | 12.64 | 25.09 | 21.17 |
Receivables | 201.66 | 223.96 | 230.06 | 235.65 | 190.12 |
Inventory | 38.2 | 38.14 | 29.51 | 56.34 | 73.08 |
Prepaid Expenses | 64.29 | 67.47 | 65.65 | 63.16 | 38.26 |
Other Current Assets | 33.89 | 36.02 | 40.15 | 42.06 | 27.96 |
Total Current Assets | 1,119 | 1,664 | 1,489 | 1,315 | 1,225 |
Property, Plant & Equipment | 53.09 | 56.58 | 72.09 | 71.47 | 74.01 |
Goodwill | 283.19 | 283.19 | 1,073 | 1,073 | 14,504 |
Other Intangible Assets | 1,297 | 1,431 | 1,678 | 1,837 | 1,910 |
Long-Term Deferred Charges | 59.53 | 61.86 | 58.67 | 33.8 | 8.85 |
Other Long-Term Assets | 46.27 | 19.63 | 21.59 | 14.74 | 11.85 |
Total Assets | 2,858 | 3,517 | 4,392 | 4,345 | 17,735 |
Accounts Payable | 47.97 | 33.13 | 43.64 | 47.69 | 47.26 |
Accrued Expenses | 220.79 | 198.72 | 195.52 | 169.29 | 142.84 |
Current Portion of Long-Term Debt | - | 550.72 | - | - | 13.31 |
Current Portion of Leases | 11.04 | 10.34 | 10.75 | 13.59 | 12.69 |
Current Income Taxes Payable | - | - | - | 3.82 | 3.1 |
Current Unearned Revenue | 62.31 | 79.3 | 95.66 | 101.83 | 75.57 |
Other Current Liabilities | 62.64 | 69.33 | 75.05 | 63.55 | 36.25 |
Total Current Liabilities | 404.74 | 941.54 | 420.62 | 399.77 | 331.01 |
Long-Term Debt | 994.93 | 991.42 | 1,539 | 1,535 | 1,235 |
Long-Term Leases | 34.2 | 32.14 | 42.84 | 38.04 | 41.77 |
Long-Term Unearned Revenue | 9.14 | 9.79 | 13.62 | 11.95 | 3.83 |
Long-Term Deferred Tax Liabilities | 28.95 | 49.85 | 49.45 | 50.94 | 75.78 |
Other Long-Term Liabilities | 0.64 | 0.72 | 1.08 | 1.62 | 1.49 |
Total Liabilities | 1,473 | 2,025 | 2,066 | 2,038 | 1,689 |
Common Stock | 0.18 | 0.17 | 0.17 | 0.16 | 0.16 |
Additional Paid-In Capital | 17,850 | 17,759 | 17,592 | 17,359 | 17,473 |
Retained Earnings | -16,430 | -16,230 | -15,229 | -15,008 | -1,421 |
Comprehensive Income & Other | -34.73 | -38.39 | -36.99 | -42.78 | -6.29 |
Shareholders' Equity | 1,386 | 1,491 | 2,326 | 2,308 | 16,046 |
Total Liabilities & Equity | 2,858 | 3,517 | 4,392 | 4,345 | 17,735 |
Total Debt | 1,040 | 1,585 | 1,592 | 1,587 | 1,303 |
Net Cash (Debt) | -259.08 | -286.29 | -468.6 | -668.74 | -406.72 |
Net Cash Per Share | -1.47 | -1.68 | -2.85 | -4.14 | -2.59 |
Filing Date Shares Outstanding | 178.4 | 173.67 | 167.04 | 162.62 | 160.33 |
Total Common Shares Outstanding | 178.32 | 173.41 | 166.66 | 162.84 | 160.47 |
Working Capital | 714.39 | 722.37 | 1,068 | 915.62 | 894.43 |
Book Value Per Share | 7.77 | 8.60 | 13.96 | 14.17 | 99.99 |
Tangible Book Value | -194.57 | -223.47 | -424.9 | -602.21 | -368.7 |
Tangible Book Value Per Share | -1.09 | -1.29 | -2.55 | -3.70 | -2.30 |
Machinery | 82.06 | 74.91 | 65.76 | 56.86 | 46.45 |
Construction In Progress | 1.21 | 0.6 | 1.72 | 7.19 | 1.93 |
Leasehold Improvements | 28.92 | 25.33 | 24.29 | 13.3 | 12.98 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.